Riggs Asset Managment Co. Inc. Oncocyte Corp Transaction History

Riggs Asset Managment Co. Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	BUY	$1.38 - $2.63 $1,380 - $2,630	1,000 New	1,000 $2,000
Q3 2020 Oct 13, 2020	SELL	$1.2 - $1.89 $1,200 - $1,890	-1,000 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$1.51 - $2.27 $3,020 - $4,540	-2,000 Reduced 66.67%	1,000 $2,000
Q3 2019 Oct 31, 2019	SELL	$1.59 - $2.51 $477 - $752	-300 Reduced 9.09%	3,000 $6,000
Q1 2019 May 06, 2019	BUY	$1.47 - $5.91 $4,851 - $19,503	3,300 New	3,300 $13,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.